Loading...
Loading...
India's doxycycline imports from UNITED STATES total $97.3K across 59 shipments from 15 foreign suppliers. NewLife Medicals (USA). Inc. leads with $29.6K in import value; the top 5 suppliers together control 73.0% of this origin. Leading Indian buyers include HETERO LABS LIMITED. This corridor reflects India's pharmaceutical import demand for doxycycline — a diversified sourcing base with multiple active suppliers from UNITED STATES.

NewLife Medicals (USA). Inc. is the leading Doxycycline supplier from UNITED STATES to India, with import value of $29.6K across 4 shipments. The top 5 suppliers — NewLife Medicals (USA). Inc., PHARMACEUTICAL BUYERS INC, ESPEE BIOPHARMA & FINECHEM LLC, M/S. ENDO USA, INC, ZYDUS HEALTHCARE (USA) LLC — collectively account for 73.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | NewLife Medicals (USA). Inc. | $29.6K | 4 | 30.4% |
| 2 | PHARMACEUTICAL BUYERS INC | $17.6K | 2 | 18.0% |
| 3 | ESPEE BIOPHARMA & FINECHEM LLC | $9.9K | 2 | 10.1% |
| 4 | M/S. ENDO USA, INC | $9.8K | 5 | 10.1% |
| 5 | ZYDUS HEALTHCARE (USA) LLC | $4.2K | 6 | 4.4% |
| 6 | NEWLIFE MEDICALS (USA). INC. | $3.9K | 2 | 4.0% |
| 7 | AGRACE PHARMA. | $3.6K | 3 | 3.7% |
| 8 | ESPEE BIOPHARMA FINECHEM LLC | $3.1K | 1 | 3.2% |
| 9 | AGRACE PHARMA | $2.7K | 2 | 2.8% |
| 10 | ACTAVIS ELIZABETH LLC | $2.4K | 15 | 2.4% |
| 11 | RAFF & HALL PHARMACY | $2.1K | 3 | 2.1% |
| 12 | SPRING BIO SOLUTION | $2.1K | 1 | 2.1% |
| 13 | NEW LIFE MEDICALS (USA), INC. | $1.8K | 1 | 1.9% |
| 14 | ADIRAMEDICA LLC | $1.5K | 1 | 1.5% |
| 15 | NEW LIFE MEDICALS USA INC | $1.1K | 1 | 1.2% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | HETERO LABS LIMITED | $18.2K | 2 | 18.7% |
| 2 | STERIL-GENE LIFE SCIENCES PRIVATE LIMITED | $17.6K | 2 | 18.0% |
| 3 | ZYDUS LIFESCIENCES LIMITED | $14.8K | 8 | 15.2% |
| 4 | ETICO LIFESCIENCES PRIVATE LIMITED | $13.4K | 4 | 13.8% |
| 5 | PAR FORMULATIONS PRIVATE LIMITED | $9.8K | 5 | 10.1% |
| 6 | STRIDES PHARMA SCIENCE LIMITED | $4.6K | 9 | 4.8% |
| 7 | CIRON DRUGS AND PHARMACEUTICALS PRIVATE LIMITED | $3.1K | 1 | 3.2% |
| 8 | ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED | $2.4K | 15 | 2.4% |
| 9 | EMCURE PHARMACEUTICALS LIMITED | $2.3K | 1 | 2.3% |
| 10 | DR.REDDY'S LABORATORIES LTD | $2.1K | 2 | 2.1% |
| 11 | JODAS EXPOIM PRIVATE LIMITED | $2.1K | 1 | 2.1% |
| 12 | INTAS PHARMACEUTICALS LIMITED | $1.8K | 1 | 1.9% |
| 13 | EUGIA PHARMA SPECIALITIES LIMITED | $1.5K | 1 | 1.5% |
| 14 | LUPIN LIMITED | $1.1K | 1 | 1.2% |
| 15 | DR REDDYS LABORATORIES LIMITED | $905 | 1 | 0.9% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Doxycycline suppliers from UNITED STATES to India include NewLife Medicals (USA). Inc., PHARMACEUTICAL BUYERS INC, ESPEE BIOPHARMA & FINECHEM LLC. The leading supplier is NewLife Medicals (USA). Inc. with import value of $29.6K USD across 4 shipments. India imported Doxycycline worth $97.3K USD from UNITED STATES in total across 59 shipments.
India imported Doxycycline worth $97.3K USD from UNITED STATES across 59 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Doxycycline sourced from UNITED STATES include HETERO LABS LIMITED, STERIL-GENE LIFE SCIENCES PRIVATE LIMITED, ZYDUS LIFESCIENCES LIMITED. The largest buyer is HETERO LABS LIMITED with $18.2K in imports across 2 shipments.
The total value of Doxycycline imports from UNITED STATES to India is $97.3K USD, across 59 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
59 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists